Preclinical and Clinical Studies of Innovative Nanoformulations of Anticancer Drugs

Preclinical and Clinical Studies of Innovative Nanoformulations of Anticancer Drugs

Preclinical and Clinical Studies of Innovative Nanoformulations of Anticancer Drugs

POIR.01.01.01-00-0021/16-00 POIR.01.01.01-00-0021/16-00 Between 2016 and 2022, NanoVelos Ltd. carried out a project co-financed by the European Funds …

Wsparcie dla ochrony patentowej zgłoszenia PCT dla technologii i zastosowania nośników polisacharydowych dedykowanych do leczenia onkologicznego

Wsparcie dla ochrony patentowej zgłoszenia PCT dla technologii i zastosowania nośników polisacharydowych dedykowanych do leczenia onkologicznego

Wsparcie dla ochrony patentowej zgłoszenia PCT dla technologii i zastosowania nośników polisacharydowych dedykowanych do leczenia onkologicznego PP3/W…

Development of New Cancer Therapies Based on Selective Anticancer Immunomodulators

Development of New Cancer Therapies Based on Selective Anticancer Immunomodulators

STRATEGMED2/265503/3/NCBR/2015 The goal of this project is to develop an innovative therapeutic approach for cancer treatment – small molecule immunomodula…

A nanoscale polysaccharide-based delivery system for targeted oncological therapy with 5-fluorouracil.

A nanoscale polysaccharide-based delivery system for targeted oncological therapy with 5-fluorouracil.

PBS3/B7/24/2015 The Nano5-FU project is being carried out by NanoVelos S.A. as the leader of a consortium in collaboration with two academic…

Antibody Fragment-Conjugated Nanosystems for Targeted Therapy of Brain Infections (TARBRAINFECT)

Antibody Fragment-Conjugated Nanosystems for Targeted Therapy of Brain Infections (TARBRAINFECT)

16/EuroNanoMed/2019, Agreement signed on: 16.07.2019 Between 2019 and 2023, NanoSanguis implemented the project titled “Nanosystems Conjugated with Antibody Fra…

Nanoporous Membranes for Intrathecal (Pseudo)Delivery of Drugs (INTREPIDUS)

Nanoporous Membranes for Intrathecal (Pseudo)Delivery of Drugs (INTREPIDUS)

ENM3/IV/1/INTREPIDUS/2021, Agreement signed on: 17.12.2021 Between 2021 and 2024, NanoSanguis implemented the project titled “Nanoporous Membranes for Intrathec…

pp-thumbnail